Abstract | BACKGROUND: Prospective studies using bacterial eradication as the endpoint have demonstrated that once-daily amoxicillin is as effective as twice-daily amoxicillin for treatment of group A β-hemolytic streptococcal (GABHS) pharyngitis. OBJECTIVE: The aim of this study was to determine, in a retrospective study, whether treatment of symptomatic GABHS pharyngitis with once-daily amoxicillin was as effective in preventing clinical recurrences as twice-daily amoxicillin or cephalexin in pediatric office practice, using patient-initiated return visits for streptococcal pharyngitis as a pragmatic, clinical endpoint. METHODS: The charts of consecutive patients 2 years of age and older with laboratory-proven GABHS pharyngitis for a period of 2 years were reviewed to identify index cases of streptococcal pharyngitis and subsequent episodes. Age, weight, antibiotic treatment and time from index to subsequent episodes of GABHS pharyngitis were recorded. RESULTS: CONCLUSIONS:
Amoxicillin once-daily or twice-daily was equally effective in terms of frequency of recurrence of symptomatic GABHS pharyngitis.
|
Authors | Carlos E Armengol, J Owen Hendley |
Journal | The Pediatric infectious disease journal
(Pediatr Infect Dis J)
Vol. 31
Issue 11
Pg. 1124-7
(Nov 2012)
ISSN: 1532-0987 [Electronic] United States |
PMID | 22668807
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Amoxicillin
- Cephalexin
|
Topics |
- Amoxicillin
(administration & dosage, therapeutic use)
- Anti-Bacterial Agents
(administration & dosage, therapeutic use)
- Cephalexin
(administration & dosage, therapeutic use)
- Child
- Child, Preschool
- Drug Administration Schedule
- Drug Therapy, Combination
- Humans
- Pharyngitis
(drug therapy, microbiology)
- Retrospective Studies
- Streptococcal Infections
(drug therapy, microbiology)
- Streptococcus pyogenes
|